Lilly's Sandeep Gupta leaves to become Glenmark COO
This article was originally published in Scrip
Former chairman and managing director of Lilly's Indian operations, Sandeep Gupta, has left the company to join Glenmark Pharmaceuticals as chief operating officer. Mr Gupta spent five years in his most recent role at Lilly, where he had served since April 1993. Melt van der Spuy will succeed Mr Gupta at Lilly. He joined Lilly as a sales representative in South Africa 18 years ago, and most recently served as the company's general manager in Taiwan.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.